Epinex Diagnostics Incorporated Product Pipeline Analysis

SUMMARY

Epinex Diagnostics Incorporated Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Epinex Diagnostics Incorporated's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 7
1.2 List of Figures 8
2 Company Overview 9
2.1 Key Information 9
2.2 Financial Performance 9
2.3 Industry Outlook -- Pipelines 9
2.4 Industry Outlook -- In Vitro Diagnostics 10
3 Major Products and Services 11
3.1 Overview 11
4 Competitors 12
5 Key Employees 13
6 Locations And Subsidiaries 14
6.1 Head Office 14
7 Recent Developments 15
7.1 Product News 15
7.1.1 Oct 31, 2006: Epinex Develops Prototype For Monthly Type 2 Diabetes Test 15
8 Epinex Diagnostics Incorporated Pipeline Products 16
8.1 Epinex Diagnostics Incorporated Product Pipeline Analysis 16
8.1.1 Epinex Diagnostics Incorporated Pipeline Products By Equipment Type 16
8.1.2 Epinex Diagnostics Incorporated Pipeline Products By Development Stage 19
8.1.3 Epinex Diagnostics Incorporated Pipeline Products By Therapy Area 21
8.1.4 Epinex Diagnostics Incorporated Pipeline Products By News Summary 21
8.2 G1A Rapid Diabetes Monitoring Test 22
8.2.1 Product Description 22
8.2.2 Product Status 22
8.2.3 Product Milestone 23
8.2.4 Product Patent Details 23
8.3 Pregnancy Test 24
8.3.1 Product Description 24
8.3.2 Product Status 24
8.4 Ovulation Test 24
8.4.1 Product Description 24
8.4.2 Product Status 25
8.5 Down's Syndrome Screen Test 25
8.5.1 Product Description 25
8.5.2 Product Status 25
8.6 Troponin I 25
8.6.1 Product Description 26
8.6.2 Product Status 26
8.7 Myoglobin 26
8.7.1 Product Description 26
8.7.2 Product Status 27
8.8 Ovarian Cancer Antigen 27
8.8.1 Product Description 27
8.8.2 Product Status 27
8.9 Breast Cancer Antigen 27
8.9.1 Product Description 28
8.9.2 Product Status 28
8.10 Prostate Specific Antigen 28
8.10.1 Product Description 28
8.10.2 Product Status 29
8.11 H. pylori 29
8.11.1 Product Description 29
8.11.2 Product Status 29
8.12 Hepatitis B 30
8.12.1 Product Description 30
8.12.2 Product Status 30
8.13 Syphilis 30
8.13.1 Product Description 30
8.13.2 Product Status 31
8.14 Chlamydia Test 31
8.14.1 Product Description 31
8.14.2 Product Status 31
8.15 Toxoplasma Test 31
8.15.1 Product Description 32
8.15.2 Product Status 32
8.16 Rubella 32
8.16.1 Product Description 32
8.16.2 Product Status 33
8.17 Kidney Function Test Strip 33
8.17.1 Product Description 33
8.17.2 Product Status 33
8.18 Amphetamine Test 34
8.18.1 Product Description 34
8.18.2 Product Status 34
8.19 Cocaine Test 34
8.19.1 Product Description 34
8.19.2 Product Status 34
8.20 Morphine test 35
8.20.1 Product Description 35
8.20.2 Product Status 35
8.21 Benzodiazipine test 35
8.21.1 Product Description 35
8.21.2 Product Status 36
8.22 Saliva-based HIV test 36
8.22.1 Product Description 36
8.22.2 Product Status 36
8.23 Saliva-based neo-natal HIV test 36
8.23.1 Product Description 36
8.23.2 Product Status 37
8.24 Biochips 37
8.24.1 Product Description 37
8.24.2 Product Status 37
8.25 Epinex Quantitative Immunoassay System 38
8.25.1 Product Description 38
8.25.2 Product Status 38
9 Appendix 39
9.1 Methodology 39
9.1.1 Coverage 39
9.1.2 Secondary Research 40
9.1.3 Primary Research 40
9.1.4 Expert Panel Validation 41
9.2 Contact Us 41
9.3 About Global Markets Direct 41
9.4 Disclaimer 41

1.1 List of Tables
Table 1: Epinex Diagnostics Incorporated,Key Facts 9
Table 2: Epinex Diagnostics Incorporated, Key Employees, 13
Table 3: Epinex Diagnostics Incorporated Pipeline Products by Equipment Type 18
Table 4: Epinex Diagnostics Incorporated Pipeline Products By Development Stage 20
Table 5: Epinex Diagnostics Incorporated Pipeline Products By Therapy Area 21
Table 6: Epinex Diagnostics Incorporated Pipeline Products By News Summaries 21

1.2 List of Figures
Figure 1: Epinex Diagnostics Incorporated Pipeline Products By Equipment Type 16
Figure 2: Epinex Diagnostics Incorporated Pipeline Products By Equipment Type 17
Figure 3: Epinex Diagnostics Incorporated Pipeline Products By Development Stage 19
Figure 4: Global Markets Direct Methodology 39